Drug Profile
Lipostabil
Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Nattermann
- Developer Nonindustrial source
- Class Antiulcers; Choleretics; Cholic acids; Cytoprotectives; Gallstone therapies; Glycerophospholipids; Lipids; Phosphatidylcholines; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Atherosclerosis